QRICH1 and acute lymphoblastic leukemia: To further clarify the clinical significance of QRICH1, 226 eligible patients (Supplementary Information 1) from the TARGET-ALL-Phase II Project were assigned into high QRICH1 expression and low QRICH1 expression groups.